Bombay HC Conducts Emergency Hearing from CJ’s Residence as Court Staff Deployed for Elections  ||  Madras HC: Preventive Detention Laws are Draconian, Cannot be Used to Curb Dissent or Settle Politics  ||  HP HC: Mere Interest in a Project Cannot Justify Impleading a Non-Signatory in Arbitration  ||  J&K&L HC: Women Accused in Non-Bailable Offences Form a Distinct Class Beyond Sec 437 CrPC Rigour  ||  Bombay HC Restores IMAX’s Enforcement of Foreign Awards Against E-City, Applying Res Judicata  ||  Supreme Court Upholds Cancellation of Bail For Man Accused of Assault Causing Miscarriage  ||  J&K&L High Court Invalidates Residence-Based Reservation, Citing Violation of Article 16  ||  Kerala HC Denies Parole to Life Convict in TP Chandrasekharan Murder Case For Cousin's Funeral  ||  High Court Grants Bail to J&K Bank Manager in Multi-Crore Loan Fraud Case, Emphasizing Bail As Rule  ||  J&K HC: Civil Remedy Alone Cannot Be Used To Quash Criminal Proceedings in Enso Tower Case    

Drugs and Cosmetics (Amendment) Bill, 2015 - (30 Nov 2015)

Miscellaneous

The Drugs and Cosmetics (Amendment) Bill, 2015, set to be introduced in the Parliament’s Winter Session, 2015, proposes much needed updates to the Drugs and Cosmetics Act, 1940. The Bill, 2015 broadens the scope of the government’s powers and introduces checks and balances in the manufacture, import, distribution and sale of drugs and cosmetics in India. Clinical trials are set to be overseen by the Ethics Committee, constituted under the Bill. The Committee will also have powers to audit clinical trials and make site visits to ensure safety and well being of participants. Greater regulation and oversight, stricter punishments and vigilance outline the proactive stance the Bill proposes for the government.

Tags : DRUG AND COSMETICS   BILL   2015   ETHICS COMMITTEE  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved